Results 81 to 90 of about 417 (140)
Evaluation of bronchodilators and mucolytic agents.
Journal of postgraduate medicine, 1979 openaire +1 more source
[Bronchodilator agents in obstructive bronchitis in infants].
Revista chilena de pediatria, 1982 openaire +1 more source
[Anti-inflammatory agents and bronchodilators in bronchial asthma].
Anales de medicina interna (Madrid, Spain : 1984), 1993 openaire +1 more source
Misuse of Inhaled Bronchodilator Agents [PDF]
BMJ: British Medical Journal, 1965 K B Saunders
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Degradation of Bronchodilator Agents in Oxymix System
Journal of Pharmaceutical Sciences, 1973Abstract: Known amounts of isoproterenol, phenylephrine, and epinephrine were added to the aqueous oxymix system and thereby exposed to potential redox destruction. Thirty minutes later, recoveries of isoproterenol and phenylephrine were 89-100% and 89-108%, respectively, while the recovery of epinephrine was 53-79%.
G H, Kronberg, B H, Takman
exaly +3 more sources
In vitro studies on the relative potency of bronchodilator agents
Lung, 1985This study describes a rapid in vitro assay for the order of potency of bronchodilator drugs using specific binding of (−)-[3H] dihydroalprenolol ([3H]DHA) to rat lung membranes. Under linear conditions with respect to tissue, specific binding of [3H]DHA showed saturability, rapid kinetics of association and dissociation of radioligand, and ...
J H, Fleisher, J L, Pinnas
openaire +2 more sources
New isoquinolines as potential bronchodilator agents
Tetrahedron, 1973Abstract The syntheses of 5-hydroxy-6-hydroxymethyl, 6-hydroxy-7-hydroxymethyl and 7-hydroxy-6-hydroxymethyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolines ( 1d ), ( 1b ) and ( 1c ) respectively, are described.
S.F. Dyke, A.W.C. White, D. Hartley
openaire +1 more source
[Measurement of the effect of a bronchodilator agent].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1990Response in a bronchodilator must be expressed by the combining the largest amplitude of response with the highest reproducibility. The forced expiratory volume in the first second (FEV1) meets these conditions and thus represents the best test. The bronchodilator response is commonly expressed in percent of the initial FEV1.
openaire +1 more source
[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2004Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.
P, Le Roux, B, Le Luyer
openaire +1 more source